Is there a vaccine against RSV? After nearly 60 years, many potential candidates came at the same time

Published Date: 02 Mar 2023

You may not have heard of respiratory syncytial virus (RSV). However, it killed more than 100,000 people worldwide in 2019, making it the leading cause of death among children under the age of one.

Read Full News

Latest News

US CDC Raises Ebola Outbreak Response to Highest Level

The U.S. CDC raised its response to the Ebola outbreak in the Democratic Republic of Congo to its highest level ⁠on Friday, but said the risk of the disease spreading in the...

EMA Turns Down 3 Therapies Across Oncology, Transplantation

Tacquell, Yartemlea, and Xervyteg failed to secure positive CHMP recommendations after EMA identified major concerns with efficacy, safety, and data interpretability.

Revisiting ERCP Timing: Early vs Urgent in Cholangitis

In most patients with mild-to-moderate cholangitis, performing ERCP within 24-48 hours appears to be as effective as performing it within 24 hours.

Pediatric Renal Trauma, No Surgery for Most

Among kids with renal injuries, most receive nonoperative management; angioembolization yields better results than surgical repair among those with high-grade renal trauma.

How Exercise Transformed the Way These Doctors Practice

From personal experiences to injury to patient success stories, exercise never figured prominently in these doctors’ practice until now.

Dupilumab Reduces Exacerbations in Kids With Type 2 Asthma

Dupilumab shows benefits in reducing severe exacerbations of asthma and improving outcomes in children with type 2 asthma and monoallergen or multiallergen sensitization.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Latest News

The U.S. CDC raised its response to the Ebola outbreak in the Democratic Republic of Congo to its highest level ⁠on Friday, but said the risk of the disease spreading in the...

Tacquell, Yartemlea, and Xervyteg failed to secure positive CHMP recommendations after EMA identified major concerns with efficacy, safety, and data interpretability.

In most patients with mild-to-moderate cholangitis, performing ERCP within 24-48 hours appears to be as effective as performing it within 24 hours.

Among kids with renal injuries, most receive nonoperative management; angioembolization yields better results than surgical repair among those with high-grade renal trauma.

From personal experiences to injury to patient success stories, exercise never figured prominently in these doctors’ practice until now.

Dupilumab shows benefits in reducing severe exacerbations of asthma and improving outcomes in children with type 2 asthma and monoallergen or multiallergen sensitization.

News All Time

Does Denmark Meet WHO Target for Flu Vaccination in T1D?

As of 2022-2023 data in Denmark, influenza vaccination coverage in patients with T1D remained below the World Health Organization target of 75%, reaching only 16.9% in children and 41.8% in adults.

Medical Training: Is AI Reshaping How Doctors Learn?

Simulation, virtual reality, and AI are reshaping medical education, allowing learners to build skills, personalize training, and prepare for complex clinical scenarios.

Dust Mite Allergy May Fade Over Time in Adults, Not in Kids

Adults with house dust mite allergy may lose allergen-specific antibodies over time, and this decline is associated with reduced symptoms of rhinitis and asthma, a study finds.

One Third of Pediatric Dermatology Fellowships Fail to Match

Many pediatric dermatology fellowship positions remain unfilled from 2009 to 2023, highlighting an ongoing workforce shortage and regional disparities in access to care.

Review Finds No Reliable Chronic Urticaria Predictors

A systematic review finds no consistent clinical, laboratory, or treatment-related factors that predicted progression from acute to chronic urticaria.

World Cup 2026 Risks: Heat, Altitude, Travel

With 104 matches across 16 host cities, the 2026 World Cup can turn recovery, hydration, and sleep into decisive performance tools.

France Reports Ebola Case in Doctor Returning From Congo

A doctor who recently returned to France from a humanitarian mission in the Democratic Republic of Congo has tested ⁠positive for Ebola, marking the country's first...

Doctor With ALS Returns to Work With Help of AI

When ALS left a Brazilian psychiatrist unable to move or speak, an AI system built around her voice, knowledge, and identity allowed her to return to teaching and patient care.

US Provides Ebola Treatment for Outbreak in Congo, Bringing Trials Closer

The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials to fight the widening Ebola outbreak in Democratic...

Full NP Practice Authority Linked to Fewer Readmissions

Full practice authority for nurse practitioners is associated with low rates of readmission and emergency department visits for chronic conditions, especially in rural areas.

NP-Led Ward Rounds Linked to Lower Surgical Site Infections

Nurse practitioner-led ward rounds may reduce the overall incidence of surgical site infections and healthcare costs and shorten the length of hospital stay, a retrospective study suggests.

US CDC Concludes Hantavirus Response as Outbreak Eases

The U.S. Centers for Disease Control and Prevention said on Wednesday it has ended its response to the hantavirus ⁠outbreak linked to a cruise ship, nearly two months after...

Clostridioides difficile Care Faces a Major Setback

Under a new FDA policy, children and people with severe Clostridioides difficile infections will have less access to a potentially lifesaving, cost-effective therapy.

Drug to Prevent Organ Rejection After Kidney Transplant Tops Standard Treatment in Trial

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays)

Patient Communication Is Your Best Resource in Rheumatology

Investing time in upfront patient communication improves self-management, builds trust, and reduces the need for long-term clinic visits.

Extreme Heat: Are Health Risks Being Underestimated?

Extreme heat affects the heart, lungs, kidneys, and brain while increasing hospital admissions, preterm birth, and pressure on the healthcare system.

Recommended News For You

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

Vaccine shows promise for pancreatic cancer, study finds

Two medications might work better for breast cancers that are resistant to one.

Remote monitoring can improve recovery from cancer surgery

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

BTK Inhibitor Active in Half of Patients With Richter Transformation

Oleanolic acid from grapes may increase chemotherapy effectiveness

Recommended Articles For You

The Miracle of Thyrogen Injection: A New Hope for Thyroid Cancer Treatment 

Transformative Insights in Oncology in Daily Practice 

AI in Cancer Diagnostics and Imaging Interpretation 

The Latest Causes and Symptoms of Bowen's Disease: All You Need to Know  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

June 20, 2023, Health Bulletin No. 12.

2.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

3.

Investigations may result in novel combination therapies for early-stage lung cancers.

4.

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

5.

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

1.

Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review

2.

Cancer Susceptibility Landscapes in Precision Oncology

3.

Integrated Techniques in Oncology in the Digital Era

4.

Cancer Rates on the Rise: What Can We Do to Stop It?

5.

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

3.

Understanding the causes of anemia in adults beyond nutritional deficiencies

4.

Efficient Management of First line ALK-rearranged NSCLC

5.

Updates on the First Line Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot